Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2413]

ESTRO 2013: Commonly used drug can limit radiation damage to lungs and heart for cancer patients

ESTRO 2013: Commonly used drug can limit radiation damage to lungs and heart for cancer patients

ESTRO 2013: Intensity modulated radiotherapy reduces side effects in patients with early breast cancer

ESTRO 2013: Intensity modulated radiotherapy reduces side effects in patients with early breast cancer

AACR 2013: Study indicates novel inhibitor to overcome drug resistance induced by RAF, MEK inhibitors

AACR 2013: Study indicates novel inhibitor to overcome drug resistance induced by RAF, MEK inhibitors

AACR 2013: Intermittent treatment with vemurafenib may prevent lethal drug resistance in melanoma

AACR 2013: Intermittent treatment with vemurafenib may prevent lethal drug resistance in melanoma

AACR 2013: New type of experimental drug active in platinum-resistant ovarian cancers

AACR 2013: New type of experimental drug active in platinum-resistant ovarian cancers

Arrhythmia drug may increase cancer risk

Arrhythmia drug may increase cancer risk

IMW 2013: Assessing renal impairment in myeloma

IMW 2013: Assessing renal impairment in myeloma

Cisplatin-resistant cancer cells sensitive to experimental anticancer drugs called PARP inhibitors

Cisplatin-resistant cancer cells sensitive to experimental anticancer drugs called PARP inhibitors

EAU 13: Epigenetic changes play a key role in development of chemo resistance in BCa

EAU 13: Epigenetic changes play a key role in development of chemo resistance in BCa

EAU 13: Japanese P2 study shows potential of combined vaccine and steroid drug in castration resistant PCa

EAU 13: Japanese P2 study shows potential of combined vaccine and steroid drug in castration resistant PCa

More from ecancer